New combo therapy aims to ease pain and prevent opioid relapse
NCT ID NCT05571917
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a treatment that combines two therapies (ACT and MBRP) to help people with both chronic pain and opioid use disorder. About 160 adults already on buprenorphine will be randomly assigned to either this combined therapy or their usual care. The goal is to see if the combined therapy reduces pain interference and helps prevent relapse.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC PAIN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Michigan
Ann Arbor, Michigan, 48109, United States
-
University of New Mexico
Albuquerque, New Mexico, 87131, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Mind-Body physio program aims to tackle chronic pain and depression together
- Can we decode the different types of pain in multiple sclerosis?
- Can yoga ease the pain of endometriosis after surgery?
- A simple pressure test before surgery might reveal your risk of chronic pain
- Rewiring the brain to fight back pain?
- Can a new tool better measure opioid withdrawal?